Baroro, Kate Cess .

HRN: 08-93-53  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/23/2024
CEFTRIAXONE 1G (VIAL)
12/23/2024
12/29/2024
IV
1gm
Q12
Typhoid Fever
Waiting Final Action 
12/23/2024
METRONIDAZOLE 500MG (TAB)
12/23/2024
12/29/2024
PO
500mg
Q8
Amoebiasis
Waiting Final Action 
12/25/2024
MUPIROCIN 2%, 15G (TUBE)
12/25/2024
12/31/2024
TOPICAL
Thin Layer
BID
IV Site Infection
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: